Search Results for: KMT2A

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
SBF1 SET binding factor 1
  • Synthesis of PIPs at the ER membrane
  • RAB GEFs exchange GTP for GDP on RABs
SET SET nuclear proto-oncogene
  • Condensation of Prophase Chromosomes
  • HuR (ELAVL1) binds and stabilizes mRNA
SVIL supervillin
TAF9 TATA-box binding protein associated factor 9
  • HIV Transcription Initiation
  • RNA Polymerase II HIV Promoter Escape
  • Transcription of the HIV genome
  • HATs acetylate histones
  • RNA Polymerase II Pre-transcription Events
  • Regulation of TP53 Activity through Phosphorylation
  • RNA polymerase II transcribes snRNA genes
  • RNA polymerase II transcribes snRNA genes
  • RNA Polymerase II Promoter Escape
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase II Transcription Initiation
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
TASP1 taspase 1
  • Formation of WDR5-containing histone-modifying complexes
  • Formation of WDR5-containing histone-modifying complexes
WDR5 WD repeat domain 5
  • PKMTs methylate histone lysines
  • HATs acetylate histones
  • HATs acetylate histones
  • RMTs methylate histone arginines
  • Activation of anterior HOX genes in hindbrain development during early embryogenesis
  • RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
  • Neddylation
  • Cardiogenesis
  • Formation of WDR5-containing histone-modifying complexes
  • Epigenetic regulation of gene expression by MLL3 and MLL4 complexes
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
  • Regulation of PD-L1(CD274) transcription
  • Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome

Page 3 out of 3 pages